Jeremy Wyatt, CEO, Ametris, explains how digital endpoints improve trial sensitivity, patient centricity, and efficiency through continuous real-world data, and why early regulatory collaboration is ...

Pharma companies are getting more and more open about their digital health initiatives, which has given MobiHealthNews more opportunities this quarter than usual to chronicle pharma’s efforts around ...

The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

Teckro, a Limerick, Ireland-based maker of clinical trial software, has raised $25 million in Series C funding, bringing the company’s total backing to $43 million. TechCrunch, Reuters and others ...

Throughout the course of a clinical trial, sponsors need to collect strong, repeatable data in order to demonstrate the efficacy and safety of a drug. In trials that rely on patients to take drugs ...

Raja Shankar, VP of machine learning at IQVIA, discusses which AI capabilities sponsors are most likely to adopt first to ...

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, has been recognized for industry leadership in digital and decentralized clinical trial ...

The system distils knowledge for quick access, reducing the need to independently source information from multiple locations.

Digital twins revolutionize drug discovery by integrating AI and biological data, enhancing prediction, trial design, and ...

Virtual clinical trials and digital twins are emerging approaches to understanding mechanisms of drug responses and drug treatment heterogeneity. With the goal of providing the right drug at the right ...